Early and sensitive detection of PML-A216V mutation by droplet digital PCR in ATO-resistant acute promyelocytic leukemia-Reference-Cited by-同舟云学术

Early and sensitive detection of PML-A216V mutation by droplet digital PCR in ATO-resistant acute promyelocytic leukemia

Published:2019-01-16 Issue:6 Volume:33 Page:1527-1530
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Alfonso V.,Iaccarino L.,Ottone T.,Cicconi L.,Lavorgna S.,Divona M.,Cairoli R.,Cristiano A.,Ciardi C.,Travaglini S.,Falconi G.^ORCID,Hasan S. K.,Venditti A.,Arcese W.^ORCID,Voso M. T.^ORCID,Lo-Coco F.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-018-0298-3.pdf

Reference6 articles.

1. Lo-Coco F, Avvisati G, Vignetti M, Thiede C, Orlando SM, Iacobelli S, et al. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med. 2013;369:111–21.

2. Burnett AK, Russell NH, Hills RK, Bowen D, Kell J, Knapper S, et al. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial. Lancet Oncol. 2015;16:1295–305.

3. Iaccarino L, Ottone T, Divona M, Cicconi L, Cairoli R, Voso MT, et al. Mutations affecting both the rearranged and the unrearranged PML alleles in refractory acute promyelocytic leukaemia. Br J Haematol. 2016;172:909–13.

4. Zhu H-H, Qin Y-Z, Huang X-J. Resistance to arsenic therapy in acute promyelocytic leukemia. N Engl J Med. 2014;370:1864–6.

5. Lehmann-Che J, Bally C, de Thé H. Resistance to therapy in acute promyelocytic leukemia. N Engl J Med. 2014;371:1170–2.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mutations at proximal cysteine residues in PML impair ATO binding by destabilizing the RBCC domain;The FEBS Journal;2023-12-28

2. Phase separation is required for PML nuclear body biogenesis and function;The FASEB Journal;2023-05-23

3. PML mutants resistant to arsenic induced degradation fail to generate the appropriate SUMO and ubiquitin signals required for RNF4 and p97 recruitment;2023-01-17

4. The mythological chimera and new era of relapse prediction post-transplant;Blood Reviews;2023-01

5. Droplet digital PCR for genetic mutations monitoring predicts relapse risk in pediatric acute myeloid leukemia;International Journal of Hematology;2022-07-18